Article info
PDFSection 5: Patient safety and quality assurance
5PSQ-057 Efficacy and safety of adalimumab in the treatment of inflammatory facial granuloma secondary to silicone
Citation
5PSQ-057 Efficacy and safety of adalimumab in the treatment of inflammatory facial granuloma secondary to silicone
Publication history
- First published March 23, 2023.
Online issue publication
May 02, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2023. No commercial re-use. See rights and permissions. Published by BMJ.